Dexketoprofen

Dexketoprofen

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	M01AE17 (WHO) M02AA27 (WHO)
Legal status
Legal status	UK: POM (Prescription only)
Identifiers
IUPAC name (2S)-2-[3-(benzoyl)phenyl]propanoic acid
PubChem CID	667550
ChemSpider	580922 N
UNII	6KD9E78X68
KEGG	D07269 Y
ChEBI	CHEBI:76128 N
ChEMBL	ChEMBL75435 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C16H14O3
Molar mass	254.28056 g/mol
3D model (JSmol)	Interactive image
SMILES C[C@@H](c1cccc(c1)C(=O)c2ccccc2)C(=O)O
InChI InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m0/s1 N Key:DKYWVDODHFEZIM-NSHDSACASA-N N
NY (what is this?)  (verify)

WikiDoc Resources for Dexketoprofen
Articles
Most recent articles on Dexketoprofen Most cited articles on Dexketoprofen Review articles on Dexketoprofen Articles on Dexketoprofen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dexketoprofen Images of Dexketoprofen Photos of Dexketoprofen Podcasts & MP3s on Dexketoprofen Videos on Dexketoprofen
Evidence Based Medicine
Cochrane Collaboration on Dexketoprofen Bandolier on Dexketoprofen TRIP on Dexketoprofen
Clinical Trials
Ongoing Trials on Dexketoprofen at Clinical Trials.gov Trial results on Dexketoprofen Clinical Trials on Dexketoprofen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dexketoprofen NICE Guidance on Dexketoprofen NHS PRODIGY Guidance FDA on Dexketoprofen CDC on Dexketoprofen
Books
Books on Dexketoprofen
News
Dexketoprofen in the news Be alerted to news on Dexketoprofen News trends on Dexketoprofen
Commentary
Blogs on Dexketoprofen
Definitions
Definitions of Dexketoprofen
Patient Resources / Community
Patient resources on Dexketoprofen Discussion groups on Dexketoprofen Patient Handouts on Dexketoprofen Directions to Hospitals Treating Dexketoprofen Risk calculators and risk factors for Dexketoprofen
Healthcare Provider Resources
Symptoms of Dexketoprofen Causes & Risk Factors for Dexketoprofen Diagnostic studies for Dexketoprofen Treatment of Dexketoprofen
Continuing Medical Education (CME)
CME Programs on Dexketoprofen
International
Dexketoprofen en Espanol Dexketoprofen en Francais
Business
Dexketoprofen in the Marketplace Patents on Dexketoprofen
Experimental / Informatics
List of terms related to Dexketoprofen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dexketoprofen is a non-steroidal anti-inflammatory drug. It is manufactured by Menarini, under the tradename Keral. It is available in the UK, as dexketoprofen trometamol, as a prescription-only drug and in Latin America as Enantyum, produced by Menarini. Also, in Italy and Spain it is available as an over the counter-drug under the tradename respectively Enantyum, Ketesgel. Both in Lithuania and Estonia it is available as over the counter-drug under tradename Dolmen. In Mexico it is available in tablet form as "Stadium" made by Menarini in Luxemburg.

Indications

Short-term treatment of mild to moderate pain, including dysmenorrhoea.

Pharmacology

Dexketoprofen belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of chemicals in the body called prostaglandins. Prostaglandins are produced in response to injury or certain diseases and would otherwise go on to cause swelling, inflammation and pain. By blocking cyclo-oxygenase, dexketoprofen prevents the production of prostaglandins and therefore reduces inflammation and pain. Along with Peripheral analgesic action it possesses central analgesic action.

Warning

1. This medicine may cause dizziness and so may affect your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance.
2. This medicine is not for long term use

Use with caution in

1. Decreased heart function
2. Disorders involving the formation of blood cells (haematopoietic disorders)
3. Elderly people
4. Excess retention of water in the body tissues (fluid retention)
5. History of allergies
6. Long-term inflammation of skin and some internal organs (systemic lupus erythematosus)
7. Low volume of circulating blood (hypovolaemia)
8. Mild to moderately decreased liver function
9. Mildly decreased kidney function
10. Syndrome with symptoms of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon (mixed connective tissue disease)

Not to be used in

1. Active bleeding
2. Allergy to any of its ingredients
3. Allergy to aspirin or other medicines in this class
4. Asthma or history of asthma
5. Bleeding disorders
6. Bleeding from the stomach or intestines
7. Breastfeeding
8. Children
9. Crohn's disease
10. History of stomach or duodenal ulcers or indigestion
11. Inflammation of the bowel and back passage
12. Inherited tendency to bleed (haemorrhagic diathesis)
13. Moderate to severely decreased kidney function
14. Peptic ulcers
15. Pregnancy
16. Severe heart failure
17. Severely decreased liver function

Dose

In the USA: Adult: 12.5 mg of ketoprofen every 4–6 hours as needed, or 25 mg every 8 hours as needed; max 75 mg daily. Elderly: initially max 50 mg daily as needed. Child: not recommended.

In Europe: As prescribed, the dosage is variable being consistent with the nature, severity and duration of the pain episode. Currently the prescribed amount is 25 mg every 8 hours, although the daily dosage should not exceed 75 mg. In elderly patients, light to moderate liver and renal failure, the maximum dosage is set at a maximum of 50 mg/24h. Dexketoprofen is currently not prescribed to children under the age of 18.

Citations

[2]